FEMALE UROGENITAL DISEASES
Clinical trials for FEMALE UROGENITAL DISEASES explained in plain language.
Never miss a new study
Get alerted when new FEMALE UROGENITAL DISEASES trials appear
Sign up with your email to follow new studies for FEMALE UROGENITAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…
Matched conditions: FEMALE UROGENITAL DISEASES
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Immunotherapy combo may let bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab with or without relatlimab) before surgery can eliminate bladder cancer completely, allowing some patients to avoid bladder removal. About 90 adults with stage II-IIIa bladder cancer that has spread into the muscl…
Matched conditions: FEMALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC